Xeris Biopharma Holdings XERS
NASDAQ XERS
$10.78 -0.35 (-3.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Deferred Taxes (2023 - 2024)

Updated

Xeris Biopharma Holdings (XERS) reported Deferred Taxes of -$2.27 million for FY2024, compared with -$1.25 million in FY2023.

Analysis

Xeris Biopharma Holdings (XERS) Deferred Taxes (2023 - 2024) Analysis & Trends

  • According to Business Quant data, Deferred Taxes came in at -$1.25 million in FY2023 and -$1.42 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 Xeris Biopharma Holdings 1.86 Bn 1.43 Bn 79.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -3.32 Mn
Jun 30, 2024 749,000.00
Mar 31, 2024 307,000.00
Dec 31, 2023 -1.25 Mn
Sep 30, 2023 675,000.00
Jun 30, 2023 -675,000.00
API Access

Xeris Biopharma Holdings Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=XERS&period=max&api_key=YOUR_API_KEY